London Gérard M, Guérin Alain P, Marchais Sylvain J, Métivier Fabien, Pannier Bruno, Adda Hasan
Service d'Hémodialyse, Hôpital F.H. Manhès, Fleury-Mérogis, France.
Nephrol Dial Transplant. 2003 Sep;18(9):1731-40. doi: 10.1093/ndt/gfg414.
Cross-sectional and follow-up studies on end-stage renal disease patients showed that arterial calcifications are associated with cardiovascular (CV) morbidity and are an independent predictor of all-cause and CV mortality. However, these studies did not examine the impact on prognosis according to the type of calcification, i.e. intimal vs medial. Arterial media calcification (AMC), a non-occlusive condition, affects haemodynamics differently from arterial intima calcification (AIC), which occurs in atherosclerotic plaques. The aim of this study was to investigate the prognostic value of AMC in relationship to all-cause or CV mortality for stable haemodialysis (HD) patients.
We included 202 such patients in the present study. At baseline, soft-tissue native radiograms of the pelvis and the thigh were analysed for the presence and type (AMC vs AIC) of arterial calcifications. All patients underwent B-mode ultrasonography of the common carotid artery to determine the presence of atherosclerotic calcified plaques, measurement of aortic pulse wave velocity and echocardiography.
AIC was usually observed in older patients with a clinical history of atherosclerosis before starting HD treatment and typical risk factors associated with atherosclerotic disease. AMC was observed in young and middle-aged patients without conventional atherosclerotic risk factors. AMC was closely associated with the duration of HD and calcium-phosphate disorders, including the oral dose of elemental calcium prescribed as phosphate binder (CaCO(3)). Compared to patients with AIC, patients with AMC had a longer survival, but in turn their survival was significantly shorter than that of patients without calcifications.
AMC is a strong prognostic marker of all-cause and CV mortality in HD patients, independently of classical atherogenic factors. The principal effect of AMC on arterial function is increased arterial stiffness.
对终末期肾病患者的横断面研究和随访研究表明,动脉钙化与心血管(CV)发病率相关,并且是全因死亡率和CV死亡率的独立预测因子。然而,这些研究并未根据钙化类型(即内膜钙化与中膜钙化)来研究对预后的影响。动脉中膜钙化(AMC)是一种非阻塞性病变,其对血流动力学的影响与发生在动脉粥样硬化斑块中的动脉内膜钙化(AIC)不同。本研究的目的是探讨AMC对于稳定血液透析(HD)患者全因或CV死亡率的预后价值。
本研究纳入了202例此类患者。在基线时,分析骨盆和大腿的软组织X线平片,以确定动脉钙化的存在及类型(AMC与AIC)。所有患者均接受了颈总动脉B型超声检查,以确定动脉粥样硬化钙化斑块的存在、测量主动脉脉搏波速度并进行超声心动图检查。
AIC通常见于开始HD治疗前有动脉粥样硬化临床病史且伴有动脉粥样硬化疾病典型危险因素的老年患者。AMC见于无传统动脉粥样硬化危险因素的中青年患者。AMC与HD病程及钙磷紊乱密切相关,包括作为磷结合剂使用的元素钙(碳酸钙)的口服剂量。与AIC患者相比,AMC患者的生存期更长,但反过来,他们的生存期明显短于无钙化的患者。
AMC是HD患者全因和CV死亡率的有力预后标志物,独立于经典的致动脉粥样硬化因素之外。AMC对动脉功能的主要影响是增加动脉僵硬度。